Clinical Trials Browser

Interventional × Ganglioneuroma × CNS × Clear all

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

NCT04040088 2026-03-31

An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors

Phase EARLY_PHASE1 Active not recruiting

20 enrolled

CNS

Ganglioneuroma, Neuroblastoma, Ganglioneuroblastoma

NCT04923126 2026-02-04

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Phase 1/2 Recruiting

132 enrolled

CNS

Astrocytoma, Ganglioneuroma, Oligodendroglioma, Neoplasms, Neuroepithelial, Ganglioglioma, Neurocytoma

NCT05192980 2025-07-22

BIOPORTAL

Phase NA Recruiting

600 enrolled

CNS

Ganglioneuroma, Neuroblastoma, Ganglioneuroblastoma

NCT02684058 2023-12-13

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

Phase 2 Completed

151 enrolled 45 charts 1 FDA

CNS

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Oligodendroglioma, Ganglioglioma, Neurocytoma

NCT01999270 2016-10-21

Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors

Phase 1 Completed

6 enrolled

CNS

Astrocytoma, Ganglioneuroma, Glioma, Ganglioglioma

Clinical Trials

Pediatric Long-Term Follow-up and Rollover Study

An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

BIOPORTAL

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors